… Hence, we conclude that Akk’s relative abundance could represent a reliable biomarker
of favorable or dismal prognosis for patients receiving immunotherapy with PD-1 blockade. It …

… At the second visit a few days after, if s/he agreed, the subject signed informed consent
and was randomized. At the time of enrollment, demographic data and medical history were …

… The drug’s efficacy has been recently confirmed in a randomized controlled phase III study
comparing crizotinib with cisplatin/pemetrexed doublet chemotherapy in first-line setting (…

… various malignant diseases such as Hodgkin’s disease, cervical cancer, anal cancer, skin
… Lung involvement by malignancies such as Kaposi’s sarcoma and nonHodgkin’s lymphoma …

Background Concurrent chemotherapy and thoracic radiotherapy followed by prophylactic
cranial irradiation (PCI) is the standard treatment in limited-disease small-cell lung cancer (LD…

The incidence of lung cancer is rising in pregnancy, which is diagnosed on stage III–IV in 98%.
Almost half of these patients are non-smokers, who are associated with more epidermal …

Objectives The understanding of histo-molecular mechanisms associated with resistance to
osimertinib is a critical step to define the optimal treatment strategy in advanced EGFR-…

… Patient F’s locally advanced adenocarcinoma was initially treated with pemetrexed–cisplatin
and concomitant thoracic radiotherapy. Eighteen months later, thoracic progression was …

The anti-tumour and anti-metastatic properties of heparins have not been tested in patients
with early stage cancer. Whether adjuvant low molecular weight heparin (LMWH) tinzaparin …

… When only FFPE samples were available, DNA was extracted using QIAamp DNA FFPE
Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. This study …